UA112089C2 - SOLID MEDICINAL FORM OF SODIUM AND SOPHODIC EFFECTS OF DOXYLAMINE COMBINED - Google Patents
SOLID MEDICINAL FORM OF SODIUM AND SOPHODIC EFFECTS OF DOXYLAMINE COMBINEDInfo
- Publication number
- UA112089C2 UA112089C2 UAA201403968A UAA201403968A UA112089C2 UA 112089 C2 UA112089 C2 UA 112089C2 UA A201403968 A UAA201403968 A UA A201403968A UA A201403968 A UAA201403968 A UA A201403968A UA 112089 C2 UA112089 C2 UA 112089C2
- Authority
- UA
- Ukraine
- Prior art keywords
- doxylamine
- combined
- sophodic
- sodium
- effects
- Prior art date
Links
- HCFDWZZGGLSKEP-UHFFFAOYSA-N doxylamine Chemical compound C=1C=CC=NC=1C(C)(OCCN(C)C)C1=CC=CC=C1 HCFDWZZGGLSKEP-UHFFFAOYSA-N 0.000 title abstract 2
- 229960005178 doxylamine Drugs 0.000 title abstract 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 title 1
- 229910052708 sodium Inorganic materials 0.000 title 1
- 239000011734 sodium Substances 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
- 235000011925 Passiflora alata Nutrition 0.000 abstract 1
- 235000000370 Passiflora edulis Nutrition 0.000 abstract 1
- 235000011922 Passiflora incarnata Nutrition 0.000 abstract 1
- 240000002690 Passiflora mixta Species 0.000 abstract 1
- 235000013750 Passiflora mixta Nutrition 0.000 abstract 1
- 235000013731 Passiflora van volxemii Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000007909 solid dosage form Substances 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Винахід належить до галузі медицини та стосується твердої лікарської форми комбінованого препарату, що містить доксиламін, сухий екстракт пасифлори та допоміжні речовини з наступним співвідношенням компонентів, мас. %:The invention relates to medicine and relates to a solid dosage form of a combined preparation containing doxylamine, dry extract of passionflower and excipients with the following ratio, wt. %:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA201403968A UA112089C2 (en) | 2014-04-14 | 2014-04-14 | SOLID MEDICINAL FORM OF SODIUM AND SOPHODIC EFFECTS OF DOXYLAMINE COMBINED |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA201403968A UA112089C2 (en) | 2014-04-14 | 2014-04-14 | SOLID MEDICINAL FORM OF SODIUM AND SOPHODIC EFFECTS OF DOXYLAMINE COMBINED |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA112089C2 true UA112089C2 (en) | 2016-07-25 |
Family
ID=56562772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201403968A UA112089C2 (en) | 2014-04-14 | 2014-04-14 | SOLID MEDICINAL FORM OF SODIUM AND SOPHODIC EFFECTS OF DOXYLAMINE COMBINED |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA112089C2 (en) |
-
2014
- 2014-04-14 UA UAA201403968A patent/UA112089C2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL264413B (en) | Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa | |
| MX2016016666A (en) | Boronic acid derivatives and therapeutic uses thereof. | |
| MX2016015093A (en) | Boronic acid derivatives and therapeutic uses thereof. | |
| MX378273B (en) | ACTIVE COMPOUNDS TOWARDS BROMODOMAINS. | |
| EA201792592A1 (en) | PHARMACEUTICAL PREPARATIONS CONTAINING TENOFOVIR AND EMTRICITABIN | |
| CL2018001199A1 (en) | Therapeutic compositions for the treatment of human immunodeficiency virus | |
| JOP20140114B1 (en) | Heterocyclic compounds and their uses | |
| EA201692043A1 (en) | DOSAGE FORM IMMUNODEPRESSANT | |
| EA201792591A1 (en) | PHARMACEUTICAL PREPARATIONS | |
| IL263516B (en) | Dosage form for administration by vapor and smoking | |
| MX2015012833A (en) | ANTIBIOTIC COMPOSITIONS OF CEFTOLOZANO. | |
| MX389178B (en) | FIXED RATIO FORMULATION OF INSULIN GLARGINE/LIXISENATIDE. | |
| ECSP16084317A (en) | PHARMACEUTICAL FORMULATIONS, PREPARATION PROCESSES AND METHODS OF USE | |
| EA201500821A1 (en) | Derivatives of 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purines, their use as pharmaceuticals and pharmaceutical compounds | |
| EA201892837A1 (en) | PHYSIOLOGICALLY BALANCED COMPOUNDS FOR INJECTIONS, INCLUDING PHOSNET SUPPORTANT | |
| MX2016006087A (en) | Rapidly disintegrating formulations and methods of use. | |
| ECSP16096831A (en) | DERIVATIVES OF NAPHTHYRIDINADIONA | |
| EA201691924A1 (en) | PHARMACEUTICAL COMPOSITIONS | |
| HUE057871T2 (en) | Hyaluronan conjugates, methods and compositions containing medicinal active ingredients | |
| IN2014CH00840A (en) | ||
| MX2018014129A (en) | Pharmaceutical composition comprising eteplirsen. | |
| EA201690395A1 (en) | STABLE PHARMACEUTICAL COMPOSITION CONTAINING BISOPROLOL AND RAMIPRIL | |
| UA119441C2 (en) | Glycogen-based water solubility enhancers | |
| CL2016000397A1 (en) | Cancer treatment | |
| EA201890477A1 (en) | INCAPSULATED COMPOSITION OF FINGOLIMODA |